Nine million people in the UK are economically inactive,1 and young people are experiencing the biggest rise, with […]

Current pricing mechanisms, operating in fragmented national systems, often leave less populous and lower income countries with limited […]

Patients with rare diseases1 face many barriers to accessing highly priced “orphan” drugs—medicines developed specifically to treat rare […]

Indoor tanning is experiencing a boom in popularity, particularly among Gen Z (born 1997-2012), with social media promoting […]

Just over a year after the Infected Blood Inquiry urged the NHS to improve the safety of blood […]

Recognition that people with lived experience of disease should be equal partners in decision making about health policy […]

Medicines bring health benefits but may also cause harm. These benefits and harms are often uncertain initially because […]

Historically, patients were “wheeled in” to lecture theatres, often without consent, to demonstrate illnesses to students.1 The shift […]

Cancer is diagnosed at more advanced stages, and consequently with poorer outcomes, in the UK than in many […]

Widening inequalities in health, the cost-of-living crisis, and increasing non-communicable disease have contributed to the growth of social […]